🇺🇸 FDA

Company profile · Sponsor

EUPRAXIA

EUPRAXIA PHARMACEUTICALS INC.

EPRX · NYSE pharma VICTORIA, A1, USA
Pipeline
4
Drugs
0
Patents
3

Quick answer

EUPRAXIA (EPRX) is a pharma company. headquartered in VICTORIA, A1, USA. listed on NYSE. NovaPharmaNews links 4 pipeline programs, 0 drugs, and 3 patents to this profile..

Company facts

Ticker EPRX
Exchange NYSE
Company type pharma
Headquarters VICTORIA, A1, USA
SEC CIK 0001581178

Pipeline (4)

Search pipeline →

  1. EP-104GI

    EUPRAXIA

    Eosinophilic Esophagitis

    phase 2 small molecule active

    1 trial

  2. EP-104IAR 25 mg

    EUPRAXIA

    Osteoarthritis, Knee

    phase 2 small molecule completed

    1 trial

  3. TETRACOSACTIDE , EP-104GI

    EUPRAXIA

    Eosinophilic esophagitis

    phase 2 small molecule active

    1 trial

  4. EP-104IAR

    EUPRAXIA

    Osteoarthritis, Knee

    phase 1 small molecule completed

    1 trial

Patents (3)

Search patents →

  1. US 11351124

    Sustained release of formulations of local anesthetics

    Expires Mon Jun 02 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 11219604

    Injectable sustained release composition and method of using the same for treating inflammation in joints and pain associated therewith

    Expires Mon Jan 06 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 9987233

    Injectable sustained release composition and method of using the same for treating inflammation in joints and pain associated therewith

    Expires Mon May 31 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

What is EUPRAXIA?

EUPRAXIA (EPRX) is a pharma company. headquartered in VICTORIA, A1, USA. listed on NYSE. NovaPharmaNews links 4 pipeline programs, 0 drugs, and 3 patents to this profile..

What pipeline programs does EUPRAXIA sponsor?

We track 4 ClinicalTrials.gov-linked programs for EUPRAXIA, including EP-104GI and 3 more. Open each program for phase, modality, NCT IDs, and indication details.

Where does EUPRAXIA company data come from?

Profiles combine SEC EDGAR (CIK/ticker), ClinicalTrials.gov sponsor links, FDA drug records, and USPTO patent metadata. See our data sources page. This profile is for professional reference, not investment advice.